E-DRUG Archives (by thread)

  • [e-drug] Pakistan National University of Pharmaceutical Sciences, Zaheer-Ud-Din Babar
  • [e-drug] How can we promote rational use of medicines? (14), EPN Nairobi
  • [e-drug] WHO public hearings on public health, innovation and intellectual property, Hurst, Kathleen Susan
  • [e-drug] Sachs' Unfashionable Rx for third world aid, Merrill Goozner
  • [e-drug] BBC live discussion: are drugs too expensive?, E-Drug
  • [e-drug] How can we promote rational use of medicines? (15), Dr.S.Gopal Krishnan
  • [e-drug] Corruption in medicines procurement, E-Drug
  • [e-drug] WHO public hearings on public health, innovation & intellectual property, Hurst, Kathleen Susan
  • [e-drug] Rational Use of Medicines Resolution, Tim Reed
  • [e-drug] Job Announcement-UNICEF Supply Division-Contracts Officer, Linda Jandrup
  • [e-drug] Corruption in medicines procurement (2), Vijay Thawani
  • [e-drug] Vacancy announcement - IDA Solutions, "Jean-François Saint-Sauveur"
  • [e-drug] Educating Health Professionals about Drug and Device Promotion, Peter Mansfield
  • [e-drug] Pharmacy Education Symposium, Italy 2007, ELLIOTT, Rohan
  • [e-drug] Sach's unfahionable Rx for third world aid (2), Kae Trouilloud
  • [e-drug] Educating Health Professionals about Drug and Device Promotion (2), Peter Mansfield
  • [e-drug] Sachs' unfashionable Rx for third world aid (6), Carolyn Green
  • [e-drug] Doha Plus Five Lunch Discussion 14 Nov in Geneva, Sheila Shettle
  • [e-drug] Revolving Drug Fund - Recent evaluation study, Gamal Khalafalla Mohammed
  • [e-drug] Training in GMP for developing countries, Fabian Kong
  • [e-drug] AstraZeneca launched new 'Patient Assistance Program', Hilbrand Haak
  • [e-drug] Training in GMP for developing countries (2), Chandra Gulhati
  • [e-drug] Training in GMP for developing countries (4), Catherine Wachira
  • [e-drug] Conference on Pharmaceutical Policy Analysis 2007, E-Drug
  • [e-drug] The adaptability of (malaria) parasites, Merrill Goozner
  • [e-drug] Availability of Modern Cell Culture Rabies Vaccine, Dr Mehata
  • [e-drug] AstraZeneca launched new 'Patient Assistance Program' (4), Douglas Ball
  • [e-drug] CIPLA on 5 years Doha Declaration, CIPLA Corporate HQ
  • [e-drug] The adaptability of (malaria) parasites (2), kabiru michael
  • [e-drug] Training in GMP for developing countries (5), Kopp, Sabine
  • [e-drug] AstraZeneca launched new 'Patient Assistance Program' (5), James B. Russo
  • [e-drug] AstraZeneca launched new 'Patient Assistance Program' (7), Joana Ramos
  • [e-drug] WHO lauches global plan to combat counterfeit medical products, Wilbert Bannenberg
  • [e-drug] AstraZeneca launched new 'Patient Assistance Program' (8), Murat Civaner
  • [e-drug] MSF: Five Years After Doha, Drug Prices Are on the Rise, Sheila . SHETTLE
  • [e-drug] ARV Policy, Adherence, Program Management course July 2007 Boston, Petty, Sarah
  • [e-drug] Oxfam: Rich countries betraying their obligations to help poor countries, Rohit Malpani
  • [e-drug] Counterfeit medicines, fake medicines and the illicit market, Ghisleine Soulier
  • [e-drug] Oxfam: Rich countries betraying their obligations to help poor countries (2), Vijay Thawani
  • [e-drug] Drug Information and Pharmacovigilance Centre setup, Sosola
  • [e-drug] Access to Meds conference Milan, Italy, 17 Nov, Mai Do
  • [e-drug] Oxfam: Rich countries betraying their obligations to help poor countries (5), Vijay Thawani
  • [e-drug] MSF submission to WHO intergovernmental working group, James ARKINSTALL
  • [e-drug] ART scale up challenges (2), kabiru michael
  • [e-drug] Unique adherence challenges to ART, Noah K. Tarus
  • [e-drug] Unethical clinical trials report WEMOS & SOMO, Wilbert Bannenberg
  • [e-drug] Five years of Doha Declaration On Public Health, E-Drug
  • [e-drug] U.N. launches drive to halt fake drug boom, Leela McCullough
  • [e-drug] Research on ARV-drug managment software tools, Juerg . Draeyer
  • [e-drug] Indian Patent Searches, e-drug
  • [e-drug] Therapeutics Letter #60: "Clinical Pearls from Prescrire", Ciprian Jauca
  • [e-drug] RFI: Zinc dispersible tablet manufacturer in Asia?, Anand Shah
  • [e-drug] Essential medicines list Committee March 2007, Hill, Suzanne
  • [e-drug] WHO/FIP Handbook "Developing pharmacy practice - focus patient care", Everard, Marthe M.
  • [e-drug] Research on ARV-drug managment software tools (2), Hilbrand Haak
  • [e-drug] Labelling GMP (3), gpmohanta
  • [e-drug] BC, Canada Drug Therapy Course: March 30-31, 2007, Ciprian Jauca
  • [e-drug] Antibiotic use in surgery in Viet Nam, Julie Vezey
  • [e-drug] Zinc dispersible tablet manufacturers in Asia (2), afshan iqbal
  • [e-drug] INH prophylaxis for all HIV+ children?, Wilbert Bannenberg
  • [e-drug] The role of Universities in access to medicines, e-drug
  • [e-drug] Attacks on British and German Drug Therapy Institutes, e-drug
  • [e-drug] WHO African Regional Health Report, Andy Gray
  • [e-drug] Zinc dispersible tablet manufacturer in Asia (3), Sri
  • [e-drug] MSF: People Not Getting the Treatment They Need to Stay Alive, Sheila . SHETTLE
  • [e-drug] MSF Welcomes Move to Overcome Patent on AIDS Drug in Thailand, Sheila . SHETTLE
  • [e-drug] Overcome Patent on AIDS Drug in Thailand (2), Vijay Thawani
  • [e-drug] Multidisciplinary pharmacy education, Gregory Duncan
  • [e-drug] European Parliament resolution on AIDS and Access to medicines, Alexandra Heumber
  • [e-drug] Clinton announces lower paediatric ART prices, E-Drug
    • Mail converted by MHonArc 2.6.8